<DOC>
	<DOCNO>NCT02250638</DOCNO>
	<brief_summary>To obtain sufficient specimen correlate clinical data well-controlled prospective clinical trial collect longitudinal specimen subject diagnose stage pancreatic cancer .</brief_summary>
	<brief_title>Longitudinal Pancreatic Cancer Study</brief_title>
	<detailed_description>The study objectives describe : 1 . Obtain serum plasma specimen longitudinally collect approximately 140 subject diagnose pancreatic cancer currently undergo treatment follow-up . Specimens use evaluate CA 19-9 assay , currently development , aid monitoring recurrence progressive disease . 2 . To store remain specimen use future cancer research evaluate yet undetermined biomarkers development IVDs , include additional CA 19-9 assay , monitor course disease therapy subject diagnose pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Males female , age≥ 18 year Histologic/pathologic confirmation exocrine pancreatic cancer Any stage disease : Newly diagnose , stable , disease progression Any treatment time point : Treatment naïve , currently receive complete therapy pancreatic cancer include active monitoring . Individuals history malignant disease pancreatic cancer resect great 5 year ago currently remission eligible . Life expectancy great 6 month Able understand willing provide inform consent Males female , age &lt; 18 year No histologic/pathologic confirmation exocrine pancreatic cancer Life expectancy le 6 month Any concurrent malignancy basal squamous cell skin cancer insitu cervical cancer . Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>